Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001532085 | SCV001747482 | likely benign | not provided | 2024-09-01 | criteria provided, single submitter | clinical testing | CACNA1E: BP4, BP7 |
Gene |
RCV001532085 | SCV001894669 | benign | not provided | 2021-04-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001532085 | SCV002474894 | benign | not provided | 2025-01-25 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003458721 | SCV004179583 | benign | Developmental and epileptic encephalopathy, 69 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004752005 | SCV005359149 | likely benign | CACNA1E-related disorder | 2024-08-07 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |